Alfuzosin

3 Drugs classified under this active ingredient

α1 Blocker. Alfuzosin (HCl) 10 mg.
TABS: 30. 1 tab aft. even. meal. Funct.
sympt. BPH when surg. delayed,
during severe sympt. adenoma espec.
in elderly.
TABS: 30. 1 tab dly aft. meal for 3-4
days, incl. 1 day aft. cath. removed.
Adjuv. tmt. catheter in acute urin. retent.
in BPH. Tmt. certain funct. sympts.
benign prost. hypertrophy.
C/I: Hypersens; orthostat. hypertens,
impair. liver funct.

α1 Blocker. Alfuzosin HCl 10 mg.
E.R. TABS: 30. 10 mg dly, immed. aft.
even. meal. Swallow whole with fluid.
Not to be crushed, chew. or divid.
Start ther. on day of insert. of urethral
cath. Tmt. 3-4 days, i.e. 2-3 days
during catheterizat. and 1 day follow.
removal.
Tmt. funct. sympts. BPH, espec. if surg.
delayed. Adjuv. tmt. to cathet. in acute
urinary retent. rel. to BPH.
C/I: Known hypersens., postural
hypotens., liver fail., severe kidney fail.,
combinat. with other alpha 1 blockers,
child.

α1 Blocker. Alfuzosin (HCl) 2.5 mg, 5 mg.
XATRAL SR: F.C. TABS: 28,56x 5mg. 2 x dly, morn. &even.
Funct. sympt. BPH partic. if surg. delayed.
XATRAL XL: TABS: 10,30 x 10mg.
1 tab aft. even. meal.
Funct. sympt. BPH , part. if surg. delayed. 
1 tab dly aft. meal for 3-4 days, incl. 1
day aft. cath. removed.
Adjuv. tmt. catheter in acute urin. retent. in BPH.
C/I: Hypersens., orthostat. hypotens.,
combin. with other alpha-blockers.,
Severe hepat./ren. failure.